Last reviewed · How we verify

NCT05312853: NITOutcomes

Evaluating the Diagnostic and Predictive Value of Non-invasive Tests (NITs) on the Progression of Chronic Liver Disease.

Not yet recruiting Last updated 3 January 2024
What this trial tests

trial in Chronic Liver Disease in 250 participants. Not yet recruiting.

Timeline
15 January 2024
Primary endpoint
15 April 2034
31 December 2034

Quick facts

Lead sponsorJohannes Gutenberg University Mainz
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment250
Start date15 January 2024
Primary completion15 April 2034
Estimated completion31 December 2034
Sites1 location across Germany

Conditions studied

Sponsor

Johannes Gutenberg University Mainz

Who can join

Adults 18 to 99, any sex, with Chronic Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary objective is to study the relevance of non-invasive test (NITs) in predicting disease stage (diagnostic biomarker) and outcome (predictive biomarker) in patients with suspected or established liver disease and cirrhosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Liver Disease

Currently open trials in the same condition.

Other Johannes Gutenberg University Mainz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05312853.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing